These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 4628081

  • 21. [Antimicrobial drug therapy and microbial sensitivity tests--antifungal agents and microbial sensitivity tests].
    Yamaguchi H.
    Rinsho Byori; 1997 Jul; Suppl 105():182-90. PubMed ID: 9379538
    [No Abstract] [Full Text] [Related]

  • 22. EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts.
    Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST).
    Clin Microbiol Infect; 2008 Apr; 14(4):398-405. PubMed ID: 18190574
    [No Abstract] [Full Text] [Related]

  • 23. Two mutants selectively resistant to polyenes reveal distinct mechanisms of antifungal activity by nystatin and amphotericin B.
    Hapala I, Klobucníková V, Mazánová K, Kohút P.
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1206-9. PubMed ID: 16246082
    [Abstract] [Full Text] [Related]

  • 24. [Sensitivity of various strains of Candida to amphotericin B and nystatin (author's transl)].
    Mutlu G, Aksoycan N, Fazli A.
    Mikrobiyol Bul; 1977 Nov; 11(4):543-7. PubMed ID: 600119
    [Abstract] [Full Text] [Related]

  • 25. Non-emergence of polyene-resistant yeasts: an hypothesis.
    Hamilton-Miller JM.
    Microbios; 1974 Nov; 10A SUPPL(41):91-5. PubMed ID: 4281851
    [No Abstract] [Full Text] [Related]

  • 26. [Demonstration of the antifungal effect of Candistatin paste, a new nystatin preparation, after storage].
    Toyosi JO, Splanemann V.
    Mykosen; 1971 Mar 01; 14(3):145-7. PubMed ID: 5548645
    [No Abstract] [Full Text] [Related]

  • 27. [Study of the in vitro sensitivity of yeasts with the ATB-Fungus system].
    Martínez MM, Mendaza P, Daza RM, Sánchez G, Martín P, Martín JE, Portero F.
    Rev Esp Quimioter; 1998 Sep 01; 11(3):251-3. PubMed ID: 9795312
    [No Abstract] [Full Text] [Related]

  • 28. [Determination of in vitro susceptibility of Candida species to amphotericin B by E-test and previously proposed MIC breakpoints on two different media].
    Alp S, Sancak B, Arikan S.
    Mikrobiyol Bul; 2008 Apr 01; 42(2):293-300. PubMed ID: 18697427
    [Abstract] [Full Text] [Related]

  • 29. Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis.
    Jandourek A, Brown P, Vazquez JA.
    Clin Infect Dis; 1999 Dec 01; 29(6):1583-4. PubMed ID: 10585825
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
    Linares MJ, Muñoz JF, Solís F, Rodríguez FC, Valero A, Casal M.
    Rev Esp Quimioter; 1998 Mar 01; 11(1):64-9. PubMed ID: 9795292
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand JP, Han XY, Rolston KV, Safdar A, Raad II, Kontoyiannis DP.
    Medicine (Baltimore); 2003 Sep 01; 82(5):309-21. PubMed ID: 14530780
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of the post-antifungal effect (PAFE) of amphotericin B and nystatin against 30 zygomycetes using two different media.
    Vitale RG, Meis JF, Mouton JW, Verweij PE.
    J Antimicrob Chemother; 2003 Jul 01; 52(1):65-70. PubMed ID: 12775672
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of the etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida species.
    Pfaller MA, Boyken L, Messer SA, Tendolkar S, Hollis RJ, Diekema DJ.
    J Clin Microbiol; 2004 Nov 01; 42(11):4977-9. PubMed ID: 15528683
    [Abstract] [Full Text] [Related]

  • 36. Antifungal resistance in pathogenic fungi.
    Perea S, Patterson TF.
    Clin Infect Dis; 2002 Nov 01; 35(9):1073-80. PubMed ID: 12384841
    [Abstract] [Full Text] [Related]

  • 37. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM, Gómez D, Levalle S, Galeano M, Davel G, Vivot W, Rodero L.
    Rev Argent Microbiol; 2001 Nov 01; 33(4):217-22. PubMed ID: 11833253
    [Abstract] [Full Text] [Related]

  • 38. [Evaluation of a new automated system for the determination of antifungal sensitivity].
    Lozano MC, Parras P, Martín E.
    Enferm Infecc Microbiol Clin; 1993 Mar 01; 11(3):135-8. PubMed ID: 8499512
    [Abstract] [Full Text] [Related]

  • 39. Characterization and antibiotic sensitivity patterns of yeast-like organisms.
    Deshpande SD, Shetty CR, Murti PK.
    J Postgrad Med; 1986 Jan 01; 32(1):14-7. PubMed ID: 3528467
    [No Abstract] [Full Text] [Related]

  • 40. Characteristics of certain features of Candida strains with reduced nystatin sensitivity and assessment of the activity of new derivatives of nystatin and polyfungin against these strains.
    Kwaśniewska J.
    Mater Med Pol; 1988 Jan 01; 20(4):239-41. PubMed ID: 3249542
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.